Press Releases

Policy decisions by federal and commercial payers have expanded coverage for the TIF 2.0 procedure in 2018, extending access to effective long-term control of acid reflux symptoms REDMOND, Wash. – Federal and commercial payer plans responsible for over 100 million...

New EsophyX Z+ device supports TIF 2.0 procedure with feature set of EsophyX Z device and benefits of adult sized endoscopes. REDMOND, Wash. – EsophyX® Z+ device offers expanded endoscope compatibility and joins EndoGastric Solutions’® portfolio of specialized...

Expanded Medicare coverage and update to facility reimbursement increases patient access to non-surgical alternative for long-term control of acid reflux symptoms REDMOND, Wash. (November 14, 2017) - Medicare beneficiaries in 23 additional states have been granted...

Effective alternative for long-term control of acid reflux symptoms will now be available to over 60% of Medicare patients REDMOND, Wash. - Medicare beneficiaries in 10 Midwestern and Northeastern states will soon have reimbursed access to the Transoral Incisionless...

Study participants saw 80 percent improvement for heartburn and regurgitation one-year post procedure when hiatal hernia and gastroesophageal valve were repaired sequentially REDMOND, Wash. - EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy...

Reflux sufferers in Arizona, California, Oregon and Washington now have access to less invasive reflux treatment option.

EndoGastric Solutions®, Inc. (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today the addition of two senior executives to its leadership team: Martin Reid, Vice President of Sales, and Ted Stephens, Vice President of Marketing and Professional Education.

  Early Access Program starts in Italy with CE-marked device to meet reflux treatment demand REDMOND, Wash. – EndoGastric Solutions®, Inc. (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that the...

Plus, ASGE Special Interest Group meeting to also highlight Endoluminal Therapy for GERD EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that the company will host an educational...